The genome sequence of taurine cattle: a window to ruminant biology and evolution.

To understand the biology and evolution of ruminants, the cattle genome was sequenced to about sevenfold coverage. The cattle genome contains a minimum of 22,000 genes, with a core set of 14,345 orthologs shared among seven mammalian species of which 1217 are absent or undetected in noneutherian (marsupial or monotreme) genomes. Cattle-specific evolutionary breakpoint regions in chromosomes have a higher density of segmental duplications, enrichment of repetitive elements, and species-specific variations in genes associated with lactation and immune responsiveness. Genes involved in metabolism are generally highly conserved, although five metabolic genes are deleted or extensively diverged from their human orthologs. The cattle genome sequence thus provides a resource for understanding mammalian evolution and accelerating livestock genetic improvement for milk and meat production.

Meta-analysis and imputation refines the association of 15q25 with smoking quantity.

Smoking is a leading global cause of disease and mortality. We established the Oxford-GlaxoSmithKline study (Ox-GSK) to perform a genome-wide meta-analysis of SNP association with smoking-related behavioral traits. Our final data set included 41,150 individuals drawn from 20 disease, population and control cohorts. Our analysis confirmed an effect on smoking quantity at a locus on 15q25 (P = 9.45 x 10(-19)) that includes CHRNA5, CHRNA3 and CHRNB4, three genes encoding neuronal nicotinic acetylcholine receptor subunits. We used data from the 1000 Genomes project to investigate the region using imputation, which allowed for analysis of virtually all common SNPs in the region and offered a fivefold increase in marker density over HapMap2 (ref. 2) as an imputation reference panel. Our fine-mapping approach identified a SNP showing the highest significance, rs55853698, located within the promoter region of CHRNA5. Conditional analysis also identified a secondary locus (rs6495308) in CHRNA3.

Patent foramen ovale in patients with ischaemic stroke of unknown cause: to close? "pro closure" position

There is ample epidemiological and anecdotal evidence that a PFO increases the risk of stroke both in young and elderly patients, although only in a modest way: PFOs are more prevalent in patients with cryptogenic (unexplained) stroke than in healthy subjects, and are more prevalent in cryptogenic stroke than in strokes of other causes. Furthermore, multiple case series confirm an association of paradoxical embolism across a PFO in patients with deep vein thrombosis and/or pulmonary emboli.2. Is stroke recurrence risk in PFO-patients really not elevated when compared to PFO-free patients, as suggested by traditional observational studies? This finding is an epidemiological artifact called "the paradox of recurrence risk research" (Dahabreh & Kent, JAMA 2011) and is due to one (minor) risk factor, such as PFO, being wiped out by other, stronger risk factors in the control population.3. Having identified PFO as a risk factor for a first stroke and probably also for recurrences, we have to treat it, because treating risk factors always has paid off. No one would nowadays question the aggressive treatment of other risk factors of stroke such as hypertension, atrial fibrillation, smoking, or hyperlipidemia.4. In order to be effective, the preventive treatment has to control the risk factor (i.e. close effectively the PFO), and has to have little or no side effects. Both these conditions are now fulfilled thanks to increasing expertise of cardiologists with technically advanced closure devices and solid back up by multidisciplinary stroke teams.5. Closing a PFO does not dispense us from treating other stroke risk factors aggressively, given that these are cumulative with PFO.6. The most frequent reason why patients have a stroke recurrence after PFO closure is not that closure is ineffective, but that the initial stroke etiology is insufficiently investigated and not PFO related, and that the recurrence is due to another mechanism because of poor risk factor control.7. Similarly, the randomized CLOSURE study was negative because a) patients were included who had a low chance that their initial event was due to the PFO, b) patients were selected with a low chance that a PFO-related recurrence would occur, c) there was an unacceptable high rate of closure-related side effects, and d) the number of randomized patients was too small for a prevention trial.8. It is only a question of time until a sufficiently large randomized clinical trial with true PFO-related stroke patients and a high PFO-related recurrence risk will be performed and show the effectiveness of this closure9. PFO being a rather modest risk factor for stroke does not mean we should prevent our patients from getting the best available prevention by the best physicians in the best stroke centers Therefore, a PFO-closure performed by an excellent cardiologist following the recommendation of an expert neurovascular specialist after a thorough workup in a leading stroke center is one of the most effective stroke prevention treatments available in 2011.

Flutuação populacional de moscas-das-frutas (Diptera: Tephritidae) associadas a variedades de manga no município de José de Freitas-Piauí

O Piauí possui uma área considerável de manga, sendo um grande produtor dessa fruta no Brasil. Contudo, a presença de pragas, como as moscas-das-frutas, tem provocado grandes impactos na cadeia produtiva, pois estes insetos fazem parte de um grupo responsável por grandes prejuízos econômicos na cultura da mangueira. O conhecimento da flutuação populacional e a época de maior ocorrência de uma determinada espécie de inseto de importância econômica são requisitos indispensáveis para o estabelecimento de um controle eficiente e racional. O presente trabalho visou registrar a flutuação populacional das espécies de moscas-das-frutas associadas a variedades de manga, bem como correlacionar a ocorrência das moscas com as médias mensais de temperatura, precipitação e umidade relativa, e também avaliar os atrativos alimentares utilizados na captura dos insetos. A pesquisa foi conduzida de junho de 2004 a maio de 2005, em pomar comercial de manga (Mangifera indica L.-Anacardiaceae), das variedades Tommy Atkins, Keitt, Kent e Palmer, localizado no município de José de Freitas-Piauí-Brasil, na latitude 04º50'S e longitude 42º41'W. Anastrepha obliqua e Anastrepha serpentina são as espécies de tephritídeos predominantes na cultura da manga.

Monitoramento de coleobrocas associadas à mangueira no município de José de Freitas, Estado do Piauí

Este trabalho foi desenvolvido de junho de 2004 a maio de 2005, objetivando o reconhecimento de espécies de coleobrocas (Insecta: Coleoptera) que se encontram associadas a pomar comercial de manga (Mangifera indica) das variedades Tommy Atkins, Keitt, Kent e Palmer, no município de José de Freitas, Estado do Piauí. Foram instaladas duas armadilhas etanólicas modelo Carvalho 47 em cada área das referidas variedades e realizadas coletas semanais. As coleobrocas foram separadas dos resíduos vegetais, secas sob lâmpada e quantificadas. Posteriormente, exemplares de cada morfoespécie coletada foram identificados. Coleobrocas das famílias Bostrichidae, Cerambycidae, Curculionidae estão associadas às variedades de manga cultivadas no município de José de Freitas, Estado do Piauí, onde se destacam as espécies Hylettus seniculus (Germar) (Coleoptera: Cerambycidae), Hypothenemus sp. 1 e sp. 2. (Coleoptera: Curculionidae: Scolytinae), apresentando maior expressão numérica e variedade de morfoespécies durante o período de menor precipitação pluviométrica, fator correlacionado positivamente à família Cerambycidae.

Points to consider for prioritizing clinical genetic testing services: a European consensus process oriented at accountability for reasonableness.

Given the cost constraints of the European health-care systems, criteria are needed to decide which genetic services to fund from the public budgets, if not all can be covered. To ensure that high-priority services are available equitably within and across the European countries, a shared set of prioritization criteria would be desirable. A decision process following the accountability for reasonableness framework was undertaken, including a multidisciplinary EuroGentest/PPPC-ESHG workshop to develop shared prioritization criteria. Resources are currently too limited to fund all the beneficial genetic testing services available in the next decade. Ethically and economically reflected prioritization criteria are needed. Prioritization should be based on considerations of medical benefit, health need and costs. Medical benefit includes evidence of benefit in terms of clinical benefit, benefit of information for important life decisions, benefit for other people apart from the person tested and the patient-specific likelihood of being affected by the condition tested for. It may be subject to a finite time window. Health need includes the severity of the condition tested for and its progression at the time of testing. Further discussion and better evidence is needed before clearly defined recommendations can be made or a prioritization algorithm proposed. To our knowledge, this is the first time a clinical society has initiated a decision process about health-care prioritization on a European level, following the principles of accountability for reasonableness. We provide points to consider to stimulate this debate across the EU and to serve as a reference for improving patient management.

Determinants of antithrombotic choice for patent foramen ovale in cryptogenic stroke.

OBJECTIVE: We examined the influence of clinical, radiologic, and echocardiographic characteristics on antithrombotic choice in patients with cryptogenic stroke (CS) and patent foramen ovale (PFO), hypothesizing that features suggestive of paradoxical embolism might lead to greater use of anticoagulation. METHODS: The Risk of Paradoxical Embolism Study combined 12 databases to create the largest dataset of patients with CS and known PFO status. We used generalized linear mixed models with a random effect of component study to explore whether anticoagulation was preferentially selected based on the following: (1) younger age and absence of vascular risk factors, (2) "high-risk" echocardiographic features, and (3) neuroradiologic findings. RESULTS: A total of 1,132 patients with CS and PFO treated with anticoagulation or antiplatelets were included. Overall, 438 participants (39%) were treated with anticoagulation with a range (by database) of 22% to 54%. Treatment choice was not influenced by age or vascular risk factors. However, neuroradiologic findings (superficial or multiple infarcts) and high-risk echocardiographic features (large shunts, shunt at rest, and septal hypermobility) were predictors of anticoagulation use. CONCLUSION: Both antithrombotic regimens are widely used for secondary stroke prevention in patients with CS and PFO. Radiologic and echocardiographic features were strongly associated with treatment choice, whereas conventional vascular risk factors were not. Prior observational studies are likely to be biased by confounding by indication.

Traducció del testament de Charles Robert Darwin

L’objectiu principal d’aquest treball és assumir el que podria ser un encàrrec real d’un text jurídic. Així que, en aquest treball es tradueix un testament. Els testaments són documents a través dels quals una persona disposa els seus béns per tal que després de la seva mort una altra se’n faci càrrec. El testament escollit ha estat el de Charles Robert Darwin, que va morir el 19 d’abril de 1882 a Down, en el comptat de Kent, Anglaterra, on hi visqué 40 anys, des del 1842 fins la seva mort. Aquest testament té unes particularitats concretes, ja que fa uns 190 anys que es va firmar. El dret successori anglès, regit per la Llei de successions de protecció de la família i tuïció de 1975 és molt diferent del dret successori català. Així doncs, coneixerem les diferències entre el dret successori català i l’anglès. També, veurem tots passos que han estat necessaris per portar a terme aquest treball.

Kirja-arvostelu : Handbook of veterinary neurology

Kirjallisuusarvostelu

1977 Men's Varsity Crew

From left to right. Top: Sean Dowd, Dave Muirhead, Mike Thompson, Rick Cicchine, Mark Thomas, John Ahlstedt, Mark Reynolds, Tom Kent, and Tony Biernacki (Coach). Bottom: Bob Nguyen (Coxie).

Men's Soccer Team (1981-82)

Back Row: John MacNeil (Coach), John MacNail Jr, John Murray, Joel Walton, Frank Cipriano, Benny Grossi, Rino Berardi, Louis Famelos, Doug Rowan, Ron Di Felice Front Row: Ivan Hunt, Roger Vanoostveen, Dave Gibson, Joe Perri, Kent Mayhew, Jim Baldassarro, Guenther Baur Absent: Neil Dunsmore

Carbohydrate refeeding rapidly reverses the adaptive upregulation of human skeletal muscle pyruvate dehydrogenase kinase following a high fat diet

The time course for the reversal of the adaptive increase in pyruvate dehydrogenase kinase (PDK) activity following a 6d high fat diet (HP: 4.2 ± 0.2 % carbohydrate; 75.6 ± 0.4 % fat; 19.5 ± 0.8 % protein) was investigated in human skeletal muscle (vastus lateralis). HF feeding increased PDK activity by 44% (from 0.081 ± 0.025 min"' to 0.247 ± 0.025 mm\p < 0.05). Following carbohydrate re-feeding, (88% carbohydrate; 5% fat; 7% protein), PDK activity had returned to baseline (0.111 ± 0.014 min"') within 3h of re-feeding. The active fraction of pyruvate dehydrognease (PDHa) was depressed following 6d of the HF diet (from 0.89 ± 0.21 mmol/min/kg WW to 0.32 ± 0.05 mmol/min/kg ww,p <0.05) and increased to pre-HF levels by 45 min of post re-feeding (0.74 ±0.19 mmol/min/kg ww) and remained elevated for 3h. Western blotting analysis of the PDK isoforms, PDK4 and PDK2, revealed a 31% increase in PDK4 protein content following the HF diet, with no change in PDK2 protein. This adaptive increase in PDK4 protein content was reversed with carbohydrate re-feeding. It was concluded that the adaptive up-regulation in PDK activity and PDK4 protein content was fiilly reversed by 3h following carbohydrate re-feeding.